Advertisement

Topics

Search Results for "Abbott Dartford Murex Biotech Ltd"

13:49 EDT 23rd April 2017 | BioPortfolio

Matching Channels

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW ...

NEW YORK, NY--(Marketwired - February 23, 2017) -PharmaCyte Biotech ( OTCQB : PMCB) will join GW Pharmaceuticals, Abbott Laboratories and 66 other Read more...

Abbott Expands Diagnostics Business with $5.3 Billion Acquisition of Alere

ABBOTT PARK, Ill. and WALTHAM, Mass., April 14, 2017 /PRNewswire/ — Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of t...

#jobs #lifescience Proclinical: Technical Services Team Leader

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Proclinical: Technical Services Team Leader . Highly Competitive: Proclinical...

$4.33B deal to acquire Abbott unit finalized by J&J

Johnson & Johnson has announced the completion of its acquisition of Abbott Laboratories subsidiary Abbott Medical Optics, va -More- 

In move to nix $5.8B Alere deal, is Abbott shrewdly aiming to lower price tag?

Abbott wants out of its plan to buy Alere for $5.8 billion, but the point-of-care testing company is a perfect fit for Abbott, an analyst believes.

Abbott Agrees To Buy Alere At Lower Price

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) and Alere Inc. (ALR) said Friday that they have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere. Additio...

Abbott bläst geplante Übernahme von Alere ab

ABBOTT PARK (dpa-AFX) - Der US-Pharmakonzern Abbott Laboratories will den Diagnostikspezialisten Alere nicht länger übernehmen. Seit Vertragsunterzeichnung Anfang des Jahres habe Alere einige Rück....

Abbott Laboratories’ bittersweet week

Despite the week ending on a high note for Abbott Laboratories with an amended $5.3 billion deal to buy Alere, a warning letter from the U.S. Food and Drug Administration drew attention to is

Matching PubMed Articles

Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.

On-treatment hepatitis C virus (HCV) kinetics play an invaluable role in evaluating the efficacy of interferon-based therapies. However, the importance of HCV RNA monitoring has not been well discusse...

Response to proposed research to reverse brain death: more than regulatory failure.

In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration be...

Off they go: Single-use Technology in Future Production BioTech 2016 Conference at ZHAW Waedenswil.

"Keep up with today's single-use technology standard but also remain one step ahead" - that could have been the motto of the BioTech 2016 conference at ZHAW Waedenswil on September 5 and 6, which brou...

Comparison of Abbott RealTime genotype II, GeneMatrix restriction fragment mass polymorphism, and Sysmex HISCL HCV Gr assays for hepatitis C virus genotyping.

Hepatitis C virus (HCV) genotype is a predictive marker for treatment response. We sequentially evaluated the performances of two nucleic acid amplification tests (NAATs) and one serology assay for HC...

Investigation of the correlation between anti-HCV levels (S/Co) with HCV-RNA in the diagnosis of hepatitis C virus (HCV) infection.

Detection of borderline and/or low positive anti-HCV results by enzyme immunoassay (EIA) leads to severe problems in routine laboratories and needs confirmation with nucleic acid amplification tests w...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement